.png "Alexis Ogdie, MD photo")
Rheumatologist, Associate Professor of Medicine
University of Pennsylvania
Philadelphia, PA, United States
I am Associate Professor of Medicine and Epidemiology at the University of Pennsylvania and Deputy Director of the Penn Center for Clinical Epidemiology and Biostatistics. My research program is focused psoriatic arthritis (PsA), an inflammatory arthritis with potentially devastating outcomes that affects around 30% of patients with psoriasis. The mission of my research program is to improve outcomes in PsA through patient-centered research aiming to develop personalized medicine strategies for PsA (including adjunct therapies as proposed here), identify appropriate outcome measures for PsA, and improve early identification of the disease. I am an expert in the care of patients with PsA and founder and Director of the Penn Psoriatic Arthritis and Spondyloarthritis Program. My areas of expertise include epidemiology and pharmacoepidemiology, biostatistical methods for observational studies (e.g., complex time to event modeling, prediction modeling), outcome measures (e.g., qualitative and quantitative/psychometric assessment), and more general qualitative methods (e.g., survey, focus group and interview studies). Much of my recent work has been aimed at the design and conduct of randomized controlled trials in PsA with a particular interest in initiating pragmatic trials in PsA.
SpA Update: Radiographic and Non-Radiographic AS
Saturday, November 11, 2023
10:40 AM – 11:10 AM PT
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Celgene: Consultant (Ongoing); CorEvitas: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Gilead: Consultant (Ongoing); GSK: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Takeda: Consultant (Ongoing); UCB: Consultant (Ongoing)
Recognizing the Mimics of Axial Spondyloarthritis
Sunday, November 12, 2023
9:30 AM – 9:45 AM PT
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Celgene: Consultant (Ongoing); CorEvitas: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Gilead: Consultant (Ongoing); GSK: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Takeda: Consultant (Ongoing); UCB: Consultant (Ongoing)
Monday, November 13, 2023
6:00 PM – 8:00 PM PT
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Celgene: Consultant (Ongoing); CorEvitas: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Gilead: Consultant (Ongoing); GSK: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Takeda: Consultant (Ongoing); UCB: Consultant (Ongoing)
